FIG 3.

Effects of parenteral CDV and VIG treatments (each used alone and in combination) and triple therapy (by adding topical CDV) on survival rates (A), primary lesion areas (B), and numbers of satellite lesions (C) during a cutaneous vaccinia virus infection in cyclophosphamide-immunosuppressed SHK-1 hairless mice. The treatment regimens were the same as those described for Fig. 1. Standard error bars are shown in panels B and C. Ten mice were in each treatment group. ***, P < 0.001, compared to placebo.